Ternary complex of plasmid DNA with protamine and γ-polyglutamic acid for biocompatible gene delivery system

Biological and Pharmaceutical Bulletin

Volumn 36, Issue 11, 2013, Pages 1794-1799

  Kanda, Kosuke ^a   Kodama, Yukinobu ^a   Kurosaki, Tomoaki ^b   Imamura, Masanobu ^a   Nakagawa, Hiroo ^a   Muro, Takahiro ^a   Higuchi, Norihide ^a   Nakamura, Tadahiro ^a   Kitahara, Takashi ^a   Honda, Masayuki ^a   Sasaki, Hitoshi ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

polyglutamic acid; Gene delivery; Nanoparticle; Non viral vector; Protamine

Indexed keywords

CLATHRIN; GAMMA POLYGLUTAMIC ACID; PLASMID DNA; POLYGLUTAMIC ACID; PROTAMINE; TERNARY COMPLEX FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BIOCOMPATIBILITY; BIOSAFETY; CAVEOLA; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA PROTEIN COMPLEX; ENDOCYTOSIS; GENE EXPRESSION; GENE VECTOR; GENETIC TRANSFECTION; HUMAN; IN VITRO STUDY; MOUSE; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PINOCYTOSIS; ZETA POTENTIAL;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL LINE, TUMOR; CELL SURVIVAL; DNA; GENE TRANSFER TECHNIQUES; GENES, ERBB-1; MICE; PLASMIDS; POLYGLUTAMIC ACID; PROTAMINES;

EID: 84888623761     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.b13-00479     Document Type: Article

References (30)

1. Verma IM, Somia N. Gene therapy - promises, problems and prospects. Nature, 389, 239-242 (1997).
2. Edelstein ML, Adedi MR, Wixon J. Gene therapy clinical trials worldwide to 2007: an update. J. Gene Med., 9, 833-842 (2007).
3. Hirko A, Tang F, Hughes JA. Cationic lipid vectors for plasmid DNA delivery. Curr. Med. Chem., 10, 1185-1193 (2003).
4. Liu F, Shollenberger LM, Huang L. Non-immunostimulatory nonviral vectors. FASEB J., 18, 1779-1781 (2004).
5. Gao X, Kim KS, Liu D. Nonviral gene delivery: what we know and what is next. AAPS J., 9, E92-E104 (2007).
6. Tros de Ilarduya C, Sun Y, Düzgünes N. Gene delivery by lipoplexes and polyplexes. Eur. J. Pharm. Sci., 40, 159-170 (2010).
7. Sorgi FL, Bhattacharya S, Huang L. Protamine sulfate enhances lipid-mediated gene transfer. Gene Ther., 4, 961-968 (1997).
8. Masuda T, Akita H, Harashima H. Evaluation of nuclear transfer and transcription DNA condensed with protamine by microinjection: The use of a nuclear transfer score. FEBS Lett., 579, 2143-2148 (2005).
9. Yang VC, Port FK, Kim JS, Kim JS, Teng CL, Till GO, Wakefield TW. The use of immunobilized protamine in removing heparin and preventing protamine-induced complications during extracorporeal blood circulation. Anesthesiology, 75, 288-297 (1991).
10. Chang LC, Lee HF, Chung MJ, Yang VC. PEG-modified protamine with improved pharmacological/pharmaceutical properties as a potential protamine substitute: synthesis and in vitro evaluation. Bioconj. Chem., 16, 147-155 (2005).
11. DeLucia A 3rd, Wakefield TW, Andrews PC, Nichol BJ, Kadell AM, Wrobleski SK, Downing LJ, Staney JC. Efficacy and toxicity of differently charged polycationic protamine-like peptides for heparin anticoagulation reversal. J. Vasc. Surg., 18, 58-60 (1993).
12. Kurosaki T, Kitahara T, Fumoto S, Nishida K, Nakamura J, Niidome T, Kodama Y, Nakagawa H, To H, Sasaki H. Ternary complexes of pDNA, polyethylenimine, and -polyglutamic acid for gene delivery systems. Biomaterials, 30, 2846-2853 (2009).
13. Kurosaki T, Kitahara T, Kawakami S, Higuchi Y, Yamaguchi A, Nakagawa H, Kodama Y, Hamamoto T, Hashida M, Sasaki H. Gamma-polyglutamic acid-coated vectors for effective and safe gene therapy. J. Control. Release, 142, 404-410 (2010).
14. Prodhomme EJ, Tutt AL, Glennie MJ, Bugg TD. Multivalent conjugates of poly-gamma-D-glutamic acid from Bacillus licheniformis with antibody F(ab) and glycopeptide ligands. Bioconjug. Chem., 14, 1148-1155 (2003).
15. Schneerson R, Kubler-Kielb J, Liu TY, Dai ZD, Leppla SH, Yergey A, Backlund P, Shiloach J, Majadly F, Robbins JB. Poly(gamma-Dglutamic acid) protein conjugates induce IgG antibodies in mice to the capsule of Bacillus anthracis: a potential addition to the anthrax vaccine. Proc. Natl. Acad. Sci. U.S.A., 100, 8945-8950 (2003).
16. Prescott AG, Scott LR, U.S. Patent 0095679. (2005).
17. Warrant RW, Kim SH. Alpha-helix-double helix interaction shown in the structure of a protamine-transfer RNA complex and a nucleoprotamine model. Nature, 271, 130-135 (1978).
18. Horrow JC. Protamine: a review of its toxicity. Anesth. Analg., 64, 348-361 (1985).
19. Maruyama K, Iwasaki F, Takizawa T, Yanagie H, Niidome T, Yamada E, Ito T, Koyama Y. Novel receptor-mediated gene delivery system comprising plasmid/protamine/sugar-containing polyanion ternary complex. Biomaterials, 25, 3267-3273 (2004).
20. Li S, Huang L. In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes. Gene Ther., 4, 891-900 (1997).
21. Delgado D, Del Pozo-Rodríguez A, Solinís MÁ, Rodríguez-Gascón A. Understanding the mechanism of protamine in solid lipid nanoparticle-based lipofection: The importance of the entry pathway. Eur. J. Pharm. Biopharm., 79, 495-502 (2011).
22. Chen J, Yu Z, Chen H, Gao J, Liang W. Transfection efficiency and intracellular fate of polycation liposomes combined with protamine. Biomaterials, 32, 1412-1418 (2011).
23. Kurosaki T, Morishita T, Kodama Y, Sato K, Nakagawa H, Higuchi N, Nakamura T, Hamamoto T, Sasaki H, Kitahara T. Nanoparticles electrostatically coated with folic acid for effective gene therapy. Mol. Pharm., 8, 913-919 (2011).
24. Godbey WT, Wu KK, Mikos AG. Tracking the intracellular path of poly(ethylenimine)/DNA complexes for gene delivery. Proc. Natl. Acad. Sci. U.S.A., 96, 5177-5181 (1999).
25. Moghimi SM, Symonds P, Murray JC, Hunter AC, Debska G, Szewczyk A. A two-stage poly(ethyleneimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol. Ther., 11, 990-995 (2005).
26. Pinto MF, Morán MC, Miguel MG, Lindman B, Jurado AS, Pais AA. Controlling the morphology in DNA condensation and precipitation. Biomacromolecules, 10, 1319-1323 (2009).
27. Lv H, Zhang S, Wang B, Cul S, Yan J. Toxicity of cationic lipids and cationic polymers in gene delivery. J. Control. Release, 10, 100-109 (2006).
28. Sung MH, Park C, Kim CJ, Poo H, Soda K, Ashiuchi M. Natural and edible biopolymer poly-gamma-glutamic acid: synthesis, production, and applications. Chem. Rec., 5, 352-366 (2005).
29. Jiang G, Min SH, Kim MN, Lee DC, Lim MJ, Yeom YI. Alginate/PEI/DNA polyplexes: a new gene delivery system. Yao Xue Xue Bao, 41, 439-445 (2006).
30. Khalil I, Kogure K, Akita H, Harashima H. Uptake pathways and subsequent intracellular trafficking in nonviral gene delivery. Pharmacol. Rev., 58, 32-45 (2006).